The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinson’s Disease and Movement Disorders


(June 24, 2016) – NeuroDerm. a clinical-stage pharmaceutical company developing drugs for central nervous system diseases, presented pre-clinical data investigating ND0701, its new apomorphine product candidate for the treatment of Parkinson's disease, as well as the design of its ongoing Phase II clinical trial of ND0612H for the treatment of advanced Parkinson's diseases and additional clinical and pre-clinical data on the effect of continuous carbidopa administration on levodopa plasma levels.  The data were presented at the 20th International Congress of Parkinson's Disease and Movement Disorders taking place this month in Berlin. Read more…



Article Archive

back